NEWS ARCHIVE

Category: Feature 2

It’s finally here! If you’ve been following our social media platforms, you’ve probably noticed that we’ve been teasing a BIG announcement come September. Well, the day has finally arrived! We’re excited to announce that BIOLIFE4D has successfully 3D bioprinted a mini-heart, a significant milestone on our way towards our ultimate goal of producing a full-sized human…

Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…

Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…

Company surpasses $1M in accepted investments; expects to make significant scientific announcement in the near future CHICAGO – June 22, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying its Regulation A+ (Mini-IPO) offering, effective June 22, 2018, following…

Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues development of groundbreaking bioprinting technology CHICAGO – May 29, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for…

Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities, as Company continues development of groundbreaking bioprinting technology CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory…

Company adds renowned stem cell expert from the Texas Heart Institute to lead research as it continues development of its lifesaving heart transplant technology CHICAGO – January 2, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla…

Build a Heart. Save a life.

Scroll Up